{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"12.2","value":"5.3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"164"}],"units":"Participants"}],"description":"HPV DNA copy number is the number of HPV DNA fragments per mL of blood plasma, assessed by tumor-tissue modified viral (TTMV) testing. The natural logarithm of HPV DNA copy is used to determine correlation with gross tumor volume. Note that a natural log, by definition, has no units. The study protocol indicates that participants are analyzed as a single group, treatment arms combined. Correlation of Baseline Log HPV DNA Copy Number and Gross Tumor Volume (GTV) are reported in another outcome measure.","dispersionType":"Full Range","groups":[{"description":"IMRT 6 Weeks + Cisplatin arm: Cisplatin: 40 mg/m2 IV (intravenously) weekly for 6 weeks; Intensity-modulated radiation therapy (IMRT), 30 fractions over 6 weeks, 5 fractions per week, 2 Gray per fraction to total dose of 60 Gy.\n\nIMRT 5 weeks arm: Intensity-modulated radiation therapy (IMRT), 30 fractions over 5 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 60 Gy","id":"OG000","title":"Both Arms Combined"}],"paramType":"MEDIAN","populationDescription":"Eligible participants with baseline HPV DNA value","reportingStatus":"POSTED","timeFrame":"Baseline","title":"Natural Logarithm (ln) of Baseline HPV DNA Copy Number [for Purpose of Correlation]","type":"SECONDARY","unitOfMeasure":"ln fragments per mL"}